Heart Failure Treatment by Device

Heart Failure Treatment by Device

Bibliographic Details
Main Author:	Antoni Bayés-Genis
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2020-04-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2020.03

Similar Items

Biomarkers in Heart Failure with Preserved Ejection Fraction
by: Antoni Bayes-Genis, et al.
Published: (2022-06-01)

Editorial: The role of sex in heart failure and transplantation, volume II
by: Ana Ayesta, et al.
Published: (2023-02-01)

Biomarkers to Improve Decision-making in Acute Heart Failure
by: Rafael de la Espriella, et al.
Published: (2023-10-01)

Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review
by: Domingo Pascual-Figal, et al.
Published: (2024-09-01)

Multi-biomarker Profiling and Recurrent Hospitalizations in Heart Failure
by: Antoni Bayes-Genis, et al.
Published: (2016-10-01)

Venous Leg Compression for Tissue Decongestion in Patients With Worsening Congestive Heart Failure
by: Jose Civera, et al.
Published: (2022-07-01)

Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).
by: Josep Lupón, et al.
Published: (2014-01-01)

Heart failure risk scores in advanced heart failure patients: insights from the LEVO‐D registry
by: Pau Codina, et al.
Published: (2023-10-01)

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure
by: Julio Núñez, et al.
Published: (2017-08-01)

The DELIVER Trial: The Beginning of the End of Ejection Fraction Tyranny
by: Antoni Bayes-Genis
Published: (2022-12-01)

Epigenetic Biomarkers in Cardiovascular Diseases
by: Carolina Soler-Botija, et al.
Published: (2019-10-01)

Weight Loss in Obese Patients With Heart Failure
by: Elisabet Zamora, et al.
Published: (2016-03-01)

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
by: Oriol Iborra-Egea, et al.
Published: (2022-05-01)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
by: Domingo Pascual-Figal, et al.
Published: (2021-11-01)

Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?
by: Mar Domingo, et al.
Published: (2020-10-01)

In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure
by: Michael Pfeiffer, et al.
Published: (2024-10-01)

Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure
by: Vicente Bertomeu‐Gonzalez, et al.
Published: (2020-12-01)

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
by: Antoni Bayes‐Genis, et al.
Published: (2025-02-01)

Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis
by: Antoni Bayés de Luna, et al.
Published: (2017-07-01)

Circulating monocyte subsets and heart failure prognosis.
by: Elena Elchinova, et al.
Published: (2018-01-01)

Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
by: Gema Miñana, et al.
Published: (2022-01-01)

Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes
by: Iris Teubel, et al.
Published: (2018-02-01)

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
by: Javier Díez, et al.
Published: (2017-10-01)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
by: González-Juanatey JR, et al.
Published: (2023-03-01)

Atrial Mitral and Tricuspid Regurgitation: Sex Matters. A Call for Action to Unravel the Differences Between Women and Men
by: Francisco Gual-Capllonch, et al.
Published: (2022-06-01)

Relationship Between Bioimpedance Vector Displacement and Renal Function After a Marathon in Non-elite Runners
by: Lexa Nescolarde, et al.
Published: (2020-05-01)

Thirst distress in outpatients with heart failure in a Mediterranean zone of Spain
by: Sanna Hagelberg Eng, et al.
Published: (2021-08-01)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01)

Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis
by: Xiaobo Yang, et al.
Published: (2018-12-01)

Marathon Running Increases Synthesis and Decreases Catabolism of Joint Cartilage Type II Collagen Accompanied by High-Energy Demands and an Inflamatory Reaction
by: José A. Hernández-Hermoso, et al.
Published: (2021-10-01)

The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations
by: Julio Núñez, et al.
Published: (2021-03-01)

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
by: Josep Lupón, et al.
Published: (2021-01-01)

Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients
by: Cristina Pacho, et al.
Published: (2018-05-01)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
by: Paloma Gastelurrutia, et al.
Published: (2021-02-01)

Heart failure : device management /
by: Feldman, Arthur M. (Arthur Michael), 1949-
Published: (2010)

Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis
by: Pau Codina, et al.
Published: (2024-08-01)

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study
by: Mar Domingo, et al.
Published: (2021-12-01)

Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis
by: Elisabet Zamora, et al.
Published: (2022-12-01)

Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
by: Marta Monguió-Tortajada, et al.
Published: (2017-11-01)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
by: Antoni Bayes-Genis, et al.
Published: (2021-06-01)